The first Aspen Lipid Conference was held in 1985 to promote science relating to the broad areas of lipid, cholesterol, bile acid and lipoprotein metabolism. In 1996, to honor the legacy of Fred Kern, Jr., the conference was renamed to The Kern Aspen Lipid Conference by an unanimous vote of the Board of Directors.
The emphasis of the Conference is to provide an open forum where scientists from both academia and industry can meet and discuss science related to lipid metabolism.
The 2017 Kern Lipid Conference will be held in Vail, Colorado at the Vail Marriott Mountain Resort. Attend a world class meeting and in your free time, enjoy an outdoor adventure in the picturesque Rocky Mountains including hiking, mountain biking, fishing and white water rafting!
You can download the agenda here: https://kernconference.org/pdf/agenda_2017.pdf
The Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers. This year's IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 4 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.
Neonatal Transport has largely developed over the past 25 years becoming a cornerstone of the modern perinatal medicine. Centralization of high risk deliveries is highly beneficial to neonatal outcomes although it will be never fully achieved making Neonatal Transport efficiency an invaluable resource.
Summer Conference on Neonatology in Provence will be held in Palais des Papes, Avignon, from September 6th to September 9th 2017.
On their arrival on Wednesday 6th September, participants will have the chance to join a warm Welcoming Reception and to be introduced to the contents of the conference. From Thursday 7th to Saturday 9th September they will then attend a three-day discussion on the core themes of the event, all related to perinatal and neonatal medicine.
The scheduled sessions are dedicated to the deepening of the following topics: early neonatal nutrition, hemodynamics and oxygenation, neurology and development, perinatal infectious diseases, respiratory disorders, stabilization at birth. For Saturday 9th September it is also scheduled a farewell lunch that will mark the conclusion of this year’s edition of the conference.
Professors Umberto Simeoni, Virgilio Carnielli, Eduardo Bancalari, Paolo Manzoni, Neil Marlow and Ola D. Saugstad are among the key opinion leaders that will deliver the abovementioned lectures.
To learn more about the conference and ask for any kind of information you are welcome to contact our project manager Federica Isella at: firstname.lastname@example.org
Classically, B cell function is most intimately linked to pathogen clearance via antibody production by memory B cells and terminally differentiated plasma cells. However, there is a growing appreciation that B cells also exert powerful anti-inflammatory/regulatory effects on the immune system. Furthermore, it has become increasingly clear that these various fate decisions and functions are greatly influenced by the developmental stage and the signals encountered (both endogenous and exogenous) within the tissue microenvironment of the B cell.
This EMBO Workshop will showcase the latest findings and conceptual advancements in B cell biology, with a particular focus on 1) understanding the underlying molecular mechanisms that govern B cell phenotypes and functions; 2) how micro environmental challenges, such as those poised by microorganism residents in differential mucosal organs, influence B cell development and responses. Since pathogenic B cells contribute to diseases ranging from autoimmunity to cancer, further elucidation of these molecular pathways, how they are may change in response to environmental signals, could be important for the development of novel therapeutic targets.
Shaping The Future of Pediatrics Congress will be held from 20 to 22 September, 2017 in Rome. More than 400 participants will join this international event!! The congress will be focused on innovation in pediatrics and dedicated to pediatricians, patients and parents, entrepreneurs, enthusiasts about technology. See you there!
Submit your work and join us to attend to high quality presentations about:
Targeted drug delivery and nanocarriers, Nanomedicine for cancer diagnosis & therapy, Biological & medical nanodevices and biosensors, Tissue engineering and regenerative nanomedicine, Toxicology and risk assessment of nanomedicine systems, Nano-Imaging for diagnosis, therapy and delivery, Bionanocatalysis and nanobiosystems, Microfluidics in nanomedicine and nanobiology.
Now in its 12th year, the Cardiometabolic Health Congress is the largest, US-based, multidisciplinary conference focused solely on the management of ardiometabolic risk and the prevention of cardiovascular and metabolic disease. The 3 ½- day event offers today's busy healthcare professionals a one-of-a-kind opportunity to learn real-world solutions they can integrate immediately into their clinical practices.
Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.
Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.
5 Interactive Streams:
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.
Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers
8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.For further information, click here: http://bit.ly/22r99ki
On behalf of the members of the scientific committee and the President of ISM, we are pleased to inform you about the strategies for our annual meeting: 5th World Congress on Targeting Microbiota, which will be held in Berlin, Germany on October 26-27, 2017.
We took on consideration the conclusion of our past meeting which was held at Institut Pasteur, Paris last October 2016 and the valuable remarks and conclusion presented by Pr Peter Konturek. We decided to underline and target the following strategies: see website.
The congress is focused on the advancement of Neonatology and the science around the therapy. Over 2000 Members of the neonatal community are expected to join us in Venice for this fantastic occasion where top experts from all over the world will give insight to trending topics and issues affecting the neonatal community.
The 5th Microbiome R&D and Business Collaboration Forum: USA is set to take place on November 3 - 4 at the Paradise Point Resort & Spa in San Diego. Designed with scientists, researchers and businesses in mind, this meeting focuses on translational research and product development. Leaders from academia and industry will present on topics across the vast field of microbiome research, condensing it into two days of incisive presentations, roundtable debates and panel discussions. To see the full list of topics and speakers, view the agenda: www.global-engage.com/event/microbiome/#agenda
It is with great pleasure that we invite you to the 6th Trends in Head & Neck Oncology (THNO-6) to be held in Nice, France, November 2 - 4, 2017. This meeting will offer you up-to-date information on many aspects of head & neck cancer translated to daily practice.
With a wealth of exciting data emerging in this rapidly evolving field the 6th THNO meeting will review the state-of-the-art knowledge with emphasis on multidisciplinary decision making and management of head and neck cancer, with at the same time giving ample time to discuss preventive measures, new imaging techniques, new staging systems, rare tumors, translational research, new and innovative treatment approaches, treatment of the elderly patients, and diagnostic and therapy aspects of thyroid cancer. All disciplines involved in the treatment of head & neck cancer will be represented in integrated sessions. The translation to daily practice will be highlighted by interactive clinical case discussions facilitated by panels.
The 6th-THNO is designed for medical oncologists, surgeons, radiation oncologists, otolaryngologists, and other medical professionals involved in the treatment of patients with head and neck cancer.
We wish to invite you to the inaugural ENABLE conference, which will take place in Barcelona from 15–17 November 2017. ENABLE is the first European symposium organized by and for PhD students and Postdocs. This initiative seeks to promote excellence in the biomedical sciences in Europe by supporting young researchers, strengthening scientific careers, and bringing biomedicine closer to society. To achieve this, ENABLE is organized around three main pillars:
The ENABLE conference is about opening academia from within to promote a new research culture through a real exchange between young scientists, renowned researchers, industry professionals, and citizens. Moreover, unlike other conferences, PhD students and postdoctoral fellows are in charge of the event as a way to empower them regarding their future career choices.
Registration is now open. Early bird discounts are available until 31 July. A considerable number of travel grants are available for eligible participants who actively participate via poster presentation, short talk or micro talk. The deadline to apply for travel grants is 30 June.
Let’s spread the word to ENABLE the change!
Cambridge Healthtech Institute's Inaugural ImPACT: Immunotherapy Progress and Clinical Treatments, being held December 5-7, 2017 in San Diego, four cutting-edge conferences will showcase what’s coming next in immunotherapy. With the approval of drugs like Nivolumab and Pembrolizumab patients are already feeling the impact of cancer immunotherapy. Still, with each step forward researchers are becoming increasingly aware of the complexity and unique challenges that come with each individual’s disease. Given that not all patients respond to existing treatments, there is an enormous need to start looking at the next generation of immunotherapy solutions.
Since its debut in 1993, the annual Molecular Medicine Tri-Conference (February 11-16, 2018 in San Francisco) has become one of the world's leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world. Spanning five days, the 2018 meeting includes 16 parallel conference tracks, 7 Symposia, and 25 in-depth short courses. We are also interested in offering new skills-based training programs.
Learn more at www.TriConference.com
The congress is entirely focused on intensive care and NICU, and is organized in lectures on different topics such as resuscitation of premature infants, oxygen and ventilation, infections, surfactant deliveries, high-tech monitoring. A few sessions will be dedicated to discussions and free communication between attendees and speakers.
1- Learn more about neonates of any kind, and their destiny once adults.
2- Keep on the loop of the latest development in neonatology and pediatrics.
3- Network with leading experts on controversial topics impacting on your daily clinical activity.
4- Know more about the dramatic environmental challenges, astonishing advances for a healthy life course.
5- More for less, check the registration fees and the special fares.
Leaded by more than one thousand experts in the field of perinatal medicine, ECPM is dedicated to midwives, obstetricians, neonatologists professionals in child pathology, paediatric surgery and genetics.
The conference is divided into keynote lectures from internationally renewed experts, pleanary sessions and parallel sessions. Participants are invited to submit their researches in the form of oral or poster presentations, depending on the content of their abstracts. Many pre-congress courses with high educational value are scheduled too.